Skip to content

PHARMA PROJECT

Active Public limited companyfounded 1996active for 30 yearsPlace Cardinal Mercier 6, 1300 WavreKBO/BCE: BE 0458.257.001

Annual accounts 2025

micro format, filed on 05-01-2026, 26 days before the deadline
€83,959
▼ 14.6%
€14,333
▼ 49.9%
-€11,278
▼ €12,905
-€465,199
▼ €44,788
-4.1%
▼ 1.6 percentage points
0.03
▲ 0.03

Turnover is estimated at about €250,000, probably between €160,000 and €430,000. The micro format does not state turnover.

Balance sheet

balance sheet total €806,013 on 30-06-2025
What the company ownsHow it is paid for

in euro

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202120202019201820172016201520142013201220112010200920082007
83,95998,25989,29894,202106,15748,087106,621350,306107,668117,934162,048147,097172,828187,294190,016175,022137,98085,53889,270
58,34871,25360,23263,12872,52510,73863,059255,84271,287-12,90990,71875,85395,432103,91794,08672,748131,51044,94446,567
00000022,956167,61213,77343,19572,57905,58039,43671,954190,5741.7m24,8883,106
---1,904------9,8586,108-2,9225,288-11,19912,048--332-
-465,199-420,411-391,841-351,349-309,551-290,269-210,611-525,221--638,062-1.1m-995,913-926,697-878,134-805,602-699,914-558,606-137,908-108,982
-4.1%-2.6%-2.5%-1.0%0.2%0.6%6.2%8.1%-2.4%-0.3%4.4%6.9%9.2%10.6%11.7%13.1%15.7%35.6%-36.9%
0.030.000.010.020.010.030.010.01-0.040.010.010.010.000.010.000.000.080.11
------15.2411.32--21.6413.529.848.407.556.615.371.81-
-----242.5%-932.2%-39.6%129.6%---61.0%-41.9%-21.4%-14.6%-14.7%-17.3%-4.1%-9.0%-
-1.4%0.2%-1.5%-1.2%-0.5%-5.9%-2.4%10.5%-2.1%-7.7%-2.7%-2.9%-2.0%-1.6%-1.7%-2.3%-0.6%-3.2%-1.7%
3.283.643.073.03---------------

Debt to equity is not shown because equity is negative. Debt divided by negative equity means nothing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202120202019201820172016201520142013201220112010200920082007
Balance sheet: assets
20/58 806,013862,958936,3111.0m1.1m1.2m1.2m1.3m1.3m1.4m2.4m2.5m2.6m2.7m2.9m2.9m2.9m1.3m633,945
21/28 791,764861,391931,0171.0m1.1m1.2m1.2m1.3m1.3m1.4m2.4m2.4m2.6m2.7m2.8m2.9m2.9m1.3m621,119
22/27 791,764861,391931,0171.0m1.1m1.2m1.2m1.3m1.3m1.4m2.4m2.4m2.6m2.7m2.8m2.9m2.9m1.3m621,119
22 193,493198,353203,213208,073212,933217,793222,653227,513143,040146,2261.0m1.0m1.1m1.1m1.1m1.2m1.2m1.3m620,817
23 ----------6,822--------
24 2,0913,1364,1825,2276,94311,47516,17920,88311,7819961,2291,4631,6971,9301,552--151302
25 596,181659,902723,623791,935---------------
29/58 14,2481,5685,2946,9681,7768,0982,3155,635-27,49413,9298,7778,6643,34212,2501,7021,80411,65412,826
40/41 -----107025,635-8,1114,4055,3602,3262,291----1,503
40 ------7025,554-8,1114,4055,3601,3261,291-----
41 -----10-81----1,0001,000----1,503
54/58 11,865-3,0794,983-6,420---19,3829,5253,4166,3381,05112,250202-11,65411,322
490/1 2,3831,5682,2151,9851,7761,6681,613--------1,5001,804--
Balance sheet: equity and liabilities
10/49 806,013862,958936,3111.0m1.1m1.2m1.2m1.3m1.3m1.4m2.4m2.5m2.6m2.7m2.9m2.9m2.9m1.3m633,945
10/15 -33,296-22,018-23,645-9,6592,1607,39776,350106,584-31,596-3,996105,046169,136240,085291,454334,030383,274449,562467,932-233,702
10/11 62,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,000
10 62,00062,00062,00062,000---------------
100 62,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,000
12 743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886743,886-
14 -839,182-827,904-829,531-815,545-803,726-798,489-729,536-699,302-837,482-809,882-700,840-636,750-565,801-514,432-471,856-422,612-356,324-337,954-295,702
17/49 839,308884,976959,9561.0m1.1m1.2m1.2m1.2m1.3m1.4m2.3m2.3m2.4m2.4m2.5m2.5m2.4m846,419867,647
17 358,771461,661557,040657,535755,007849,569941,329666,348643,589738,8511.1m1.3m1.4m1.5m1.7m1.8m1.8m694,192743,035
170/4 358,771461,661557,040657,535755,007849,569941,329666,348643,589738,8511.1m1.3m1.4m1.5m1.7m1.8m1.8m694,192743,035
42/48 479,447421,979397,135358,317311,327298,366212,925530,856681,203665,5551.1m1.0m935,361881,476817,851701,616560,410149,562121,807
42 102,889103,388108,266105,01594,56291,75989,060108,33895,26290,895147,884145,116138,540132,264122,710118,237105,28948,81147,674
43 -20,386--1,544-9,171156,375154,458150,000450,00018,861---6,2334,131--
430/8 -20,386--1,544-9,171156,375154,458150,000450,00018,861---6,2334,131--
44 9,8781,6512,5402,245--23,85280802583,69481951261,50916,8597037,6951,531
440/4 9,8781,6512,5402,245--23,85280802583,69481951261,50916,8597037,6951,531
45 1,4921,0609097571,68793010,05436,513-----------
450/3 1,4921,0609097571,68793010,05436,513-----------
47/48 365,188295,494285,420250,300213,534205,67780,788229,551431,403424,403538,010839,893796,770749,186693,633560,287450,28793,05772,602
492/3 1,0901,3375,7816,01013,46310,7099,3469,81813,91219,30619,30619,30619,25819,13320,31921,90218,5522,6652,805
Income statement
76A -------239,333-435,472------87,571--
9900 83,95998,25989,29894,202106,15748,087106,621352,016107,668117,934162,048161,768186,412200,134202,588187,794147,45392,37295,981
630 69,62669,62674,21874,94777,76379,69193,293117,66298,88896,133154,808146,801146,801146,493143,330139,036149,88087,19557,078
631/4 -------1,710-----------
640/8 ----------014,67113,58412,84012,57212,7729,4736,8356,711
66A ---------485,127---------
9901 14,33328,63215,08019,25628,394-31,60413,329232,6448,78121,8017,24029626,02740,80146,68635,986-11,900-1,65732,192
75/76B ---------8--------23
75 ---------8--------23
65/66B 25,61127,00529,06631,07433,63137,34943,56366,15536,38181,19571,33071,24477,39683,37795,930102,27494,04140,59442,726
65 25,61127,00529,06631,07433,63137,34943,56366,15536,38181,19571,33071,24477,39683,37795,930102,27494,04140,59442,726
9903 -11,2781,627-13,986-11,819-5,237-68,953-30,234166,489-27,600-109,042-64,090-70,949-51,369-42,576-49,244-66,288-18,370-42,252-10,511
67/77 -------28,309-----------
9904 -11,2781,627-13,986-11,819-5,237-68,953-30,234138,180-27,600-109,042-64,090-70,949-51,369-42,576-49,244-66,288-18,370-42,252-10,511
9905 -11,2781,627-13,986-11,819-5,237-68,953-30,234138,180-27,600-109,042-64,090-70,949-51,369-42,576-49,244-66,288-18,370-42,252-10,511
Appropriation of the result
9906 -839,182-827,904-829,531-815,545-803,726-798,489-729,536-699,302-837,482-809,882-700,840-636,750-565,801-514,432-471,856-422,612-356,324-337,954-295,702
14P -827,904-829,531-815,545-803,726---------------
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The accounts for 10 older financial years, from 1997 to 2006, were filed as documents without figures as data, scans for example.

The full notes are in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 05-01-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-06-2025 micro format 05-01-2026 2026-00002525 PDF
30-06-2024 micro format 05-12-2024 2024-00615532 PDF
30-06-2023 micro format 06-12-2023 2023-00524067 PDF
30-06-2022 micro format 29-11-2022 2022-20528599 PDF
30-06-2021 micro format 09-12-2021 2021-80000025 PDF
30-06-2020 micro format 27-07-2021 2021-41000412 PDF
30-06-2019 micro format 31-01-2020 2020-04200144 PDF
30-06-2018 micro format 20-12-2018 2018-75400481 PDF
30-06-2017 micro format 11-12-2017 2017-71600204 PDF
30-06-2016 full format 25-11-2016 2016-68600497 PDF
30-06-2015 full format 07-12-2015 2015-68300513 PDF
30-06-2014 full format 08-01-2015 2015-00900215 PDF
30-06-2013 full format 06-12-2013 2013-67900287 PDF
30-06-2012 full format 14-01-2013 2013-00900512 PDF
30-06-2011 full format 01-02-2012 2012-02500030 PDF
30-06-2010 full format 01-02-2011 2011-02400548 PDF
30-06-2009 full format 08-01-2010 2010-00900121 PDF
30-06-2008 full format 15-01-2009 2009-01400105 PDF
30-06-2007 full format 04-01-2008 2008-00700088 PDF
30-06-2006 full format 10-01-2007 2007-01002676 PDF
30-06-2005 full format 29-12-2005 2005-92402590 PDF
30-06-2004 full format 13-01-2005 2005-01202787 PDF
30-06-2003 full format 05-02-2004 2004-03801661 PDF
30-06-2002 full format 24-06-2003 2003-29003170 PDF
30-06-2001 full format 14-03-2002 2002-06501065 PDF
30-06-2000 full format 05-02-2001 2001-03402289 PDF
30-06-1999 full format 19-10-2000 2000-66500717 PDF
30-06-1998 full format 13-01-1999 1999-00805148 PDF
30-06-1997 full format 02-01-1998 1998-00100179 PDF

Insights on PHARMA PROJECT

The operating result for 2025 is 50% lower than in 2024 and the lowest since 2020.

Equity is negative. Debt of €839,308 exceeds the balance-sheet total of €806,013.

Next steps